Option Care Health (NASDAQ:OPCH) Upgraded to “Buy” at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Option Care Health (NASDAQ:OPCH) from a hold rating to a buy rating in a research report sent to investors on Thursday, Marketbeat Ratings reports. They currently have $35.00 price target on the stock, up from their previous price target of $26.00.

Several other research firms also recently weighed in on OPCH. UBS Group assumed coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research upped their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a report on Tuesday, January 14th. JMP Securities reiterated a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $32.25.

Option Care Health Stock Up 1.1 %

OPCH stock opened at $30.33 on Thursday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63. The firm has a market capitalization of $5.16 billion, a PE ratio of 25.49, a P/E/G ratio of 2.11 and a beta of 1.31. The company’s 50 day simple moving average is $24.42 and its 200-day simple moving average is $27.82.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Institutional investors have recently added to or reduced their stakes in the company. FMR LLC lifted its stake in shares of Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after purchasing an additional 4,304,896 shares in the last quarter. Victory Capital Management Inc. lifted its position in Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after buying an additional 1,585,818 shares in the last quarter. Wellington Management Group LLP lifted its position in Option Care Health by 15.5% during the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after buying an additional 1,328,326 shares in the last quarter. Duquesne Family Office LLC grew its stake in Option Care Health by 172.8% during the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock worth $51,849,000 after buying an additional 1,185,613 shares during the period. Finally, Geneva Capital Management LLC acquired a new stake in shares of Option Care Health in the third quarter worth $24,679,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.